Reduced neutralization of SARS-CoV-2 variants by convalescent plasma and hyperimmune intravenous immunoglobulins for treatment of COVID-19
By using this website, you accept that you have read and understood our  cookie policy and  privacy policy

Notifications

Reduced neutralization of SARS-CoV-2 variants by convalescent plasma and hyperimmune intravenous immunoglobulins for treatment of COVID-19

Tang J, Lee Y, Ravichandran S, Grubbs G, Huang C, Stauft C, Wang T, Golding B, Golding H, Khurana S.

DOI: doi:10.1101/2021.03.19.436183
Date of Release: 2021-03-19

Immunology

0
0
0
0
0

All comments

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
No comments